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Devin Vaishnani, MD; Pratikkumar Vekaria, MD; Ravish Patel, MD; Megan White, MD;
Marvin Vaishnani, MD; Tejas Raiyani, MD.
Introduction
 Recognition of Drug-induced Liver Injury
(DILI) may be challenging as it is often
diagnosis of exclusion, unavailability of
diagnostic test and variability in
presentation.
 Many antibiotics can cause DILI but
Amoxicillin-Clavulanate has rare adverse
reaction causing mixed cholestatichepatocellular injury.

Case Presentation
 64 year old Female with no pertinent past
medical history presents with complaints of
abdominal pain and jaundice on going for
4-5 days. Described her abdominal pain as
constant, located in RUQ and epigastric
region and non radiating.
 Associated symptoms : nausea, vomiting,
metallic taste, pale colored stool and chills.
 Denies any history of hepatitis/gall stones/
alcohol use/recreational drugs.
 She reported being on amoxicillinclavulanate for 4 days for dental abscess
before onset of symptoms
 Physical examination including vital signs
were unremarkable except for RUQ
tenderness on deep palpation.
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LFTs: T. Bill 6.4 AST 218, ALT 288, ALP 331
INR – 1, lipase – 210
UDS was positive for opiates
S. Acetaminophen level < 2
S. Alcohol level < 3
Hepatitis profile was non reactive.
 Abdomen/pelvis CT scan with contrast
showed no acute abnormalities in abdomen
or pelvis.
 MRI abdomen with and without contrast with
MRCP showed mild hepatic steatosis but
otherwise unremarkable.

Clinical Course
 Patient was provided supportive care
including hydration with iv fluids,
symptomatic control.
 Symptoms improved significantly and LFTs
trended down.
 Patient was tolerating diet without issues and
was discharged home with follow up with
primary care provider.

This case report was supported by HCA and/or an HCA affiliated entity. The views expressed in this publication represent those of the
author(s) do not necessarily represent the official views of HCA or any of its affiliated entities.

 Amoxicillin-Clavulanate can cause
hepatocellular, Cholestasis or mix type of
liver injuries depending upon genetic factors
or pre-existing liver conditions.
 Early recognition and removal of offending
medication is initial mainstay of treatment
along with supportive care.
 This case demonstrates the importance of
detail history taking and review of
medications which could help narrow down
differential diagnosis.
 Our case emphasis importance of early
recognition of this reversible condition to
prevent worsening of liver failure and its
complication.
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